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Biosynthesis of the Antitumor Chromomycin A3 in
Streptomyces griseus: Analysis of the Gene Cluster
and Rational Design of Novel Chromomycin Analogs
malonyl-CoA units [5], and therefore this family of antibi-
otics belongs to the polyketide group of compounds.
The aglycons are glycosylated by oligosaccharides of
different length chain and sugar composition.
Chromomycin A3 (Figure 1A) is the main component
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Principado de Asturias (I.U.O.P.A.) of a fermentation mixture produced by S. griseus subsp.
griseus ATCC13273. Chromomycin A3 possesses theUniversidad de Oviedo
33006 Oviedo same aglycon as mithramycin but differs in the glycosyl-
ation pattern. Mithramycin is produced by differentSpain
2Division of Pharmaceutical Sciences streptomycete strains, and it contains a trisaccharide
of D-olivose, D-oliose, and D-mycarose, and a disaccha-College of Pharmacy
University of Kentucky ride of D-olivoses, while chromomycin A3 contains a
trisaccharide of D-olivose (sugar C), D-olivose (sugarLexington, Kentucky 40536
D), and 4-O-acetyl-L-chromose B (sugar E), and a disac-
charide of 4-O-acetyl-D-oliose (sugar A) and 4-O-
methyl-D-oliose (sugar B) attached at positions 2 and 6Summary
of the aglycon, respectively. The carbohydrate moieties
are major structural contributors to the biological activityThe biosynthetic gene cluster of the aureolic acid type
antitumor drug chromomycin A3 from S. griseus subsp. of chromomycin. The acetoxy groups in sugars A and
E of chromomycin contribute distinctively in the DNAgriseus has been identified and characterized. It spans
43 kb and contains 36 genes involved in polyketide complex formation by providing an additional H bond
with the 2-amino groups of G bases and thus addingbiosynthesis and modification, deoxysugar biosynthe-
sis and sugar transfer, pathway regulation and resis- more specificity to the DNA binding.
Here, we report the cloning and characterization oftance. The organization of the cluster clearly differs
from that of the closely related mithramycin. Involve- the chromomycin A3 gene cluster from S. griseus subsp.
griseus ATCC13273. We also show a rational approachment of the cluster in chromomycin A3 biosynthesis
was demonstrated by disrupting the cmmWI gene en- to generate novel chromomycin derivatives with antitu-
mor activity by specific inactivation of the ketoreductasecoding a polyketide reductase involved in side chain
reduction. Three novel chromomycin derivatives were gene cmmWI responsible for the reduction of the 4-
keto group of the 3-side chain, which occurs at the lastobtained, named chromomycin SK, chromomycin SA,
and chromomycin SDK, which show antitumor activity step of the biosynthesis.
and differ with respect to their 3-side chains. A path-
way for the biosynthesis of chromomycin A3 and its
Resultsdeoxysugars is proposed.
Cloning and Sequencing of the ChromomycinIntroduction
Biosynthetic Gene Cluster from Streptomyces
griseus subsp. griseusChromomycins, mithramycin, olivomycins, chromocyclo-
An S. griseus subsp. griseus total DNA library was con-mycin, UCH9, and durhamycin A belong to the class of
structed in the bifunctional cosmid pKC505. A total ofantitumor compounds called aureolic acids [1]. They
3300 recombinant colonies were screened by in situinhibit growth and multiplication of several tumor cell
colony hybridization using two different probes: (1) alines and also act on gram-positive bacteria. More re-
heterologous probe (PKS probe; see Experimentalcently, chromomycin as well as mithramycin were also
Procedures for details) and (2) a homologous probe gen-found to stimulate K562 cell erythroid differentiation [2],
erated using a pair of oligonucleotides specifically de-and both drugs were also suggested as neurological
signed to amplify ABC transporters involved in self-therapeutics [3] and for the treatment of HIV-1 [4]. The
resistance in producer microorganisms (ABC probe) [6].antitumor properties are ascribed to their inhibitory ef-
Thirteen cosmid clones were identified that either hy-fects on replication and transcription processes during
bridized with the PKS probe (four clones), with the ABCmacromolecular biosynthesis by interacting, in the pres-
probe (four clones), or with both probes (five clones).ence of Mg2, with G/C-rich nucleotide sequences lo-
Preliminary evidence of the involvement of the clonedcated in the minor groove of DNA.
DNA region in chromomycin biosynthesis was obtainedStructurally, the aureolic acid type compounds (with
by expressing one of the ABC hybridizing clones,the exception of chromocyclomycin) contain a tricyclic
cosGR60, in the chromomycin-sensitive strain S. albus.chromophore (aglycon) with two aliphatic side chains
Recombinant S. albus strains were shown to be able toattached at C-3 and C-7. The aglycon is synthesized
grow in the presence of 100 g/ml of chromomycin A3,through the condensation of one acetyl-CoA and nine
while control strains (only containing the vector pKC505)
did not.*Correspondence: cmendez@correo.uniovi.es (C.M.), jrohr2@uky.
edu (J.R.) A DNA region of approximately 42 kb was sequenced.
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Figure 1. Structure of Chromomycin A3 and Derivatives and Genetic Organization of the Chromomycin and Mithramycin Gene Clusters
(A) Chemical structures of chromomycin A3 and its new derivatives generating by insertional inactivation: chromomycin A3 (1), chromomycin
SA (2), chromomycin SK (3), and chromomycin SDK (4). The stereochemistry of C-2 in chromomycin SK was deduced from its NMR data in
comparison with its analog mithramycin SK (see [12]).
(B) Genetic organization of the chromomycin A3 gene cluster and its comparison with the mithramycin gene cluster.
The nucleotide sequence was deposited at the EMBL would be the third protein of the minimal cmm PKS
complex and showed similarity to different ACPs.Nucleotide Sequence Database under the accession
number AJ578458. The sequence was analyzed for puta- Three additional enzymes (CmmQ, CmmX, and
CmmY) would be involved in cyclization and aromatiza-tive open reading frames (ORFs) using the CODON-
PREFERENCE program, and the deduced amino acid tion processes. The cmmQ product would code for a
bifunctional cyclase/aromatase that would participatesequences were compared to proteins in databases us-
ing the BLAST program. Thirty-six complete ORFs were in the cyclization and aromatization of the first ring.
It is similar to various aromatases involved in type IIidentified (Figure 1B and Table 1). All the genes were
designated as cmm, with the exception of three ORFs polyketide biosynthesis, including the mithramycin [8]
aromatase, that show a C-7/C-12 first ring closure asdesignated as cmr for being related to chromomycin
resistance. necessary for chromomycin. However, the localization
of this gene in the cmm cluster is quite unusual since
it is located at a site remote from the ketosynthase
PKS Genes gene cmmP, at one end of the cluster. CmmX shows
Several genes of the cluster probably participate in poly- convincing similarity to MtmX from the mithramycin
ketide biosynthesis. Three genes (cmmP, cmmK, and gene cluster [8], proposed to be a cyclase involved in the
cmmS) would code for the minimal PKS that would be fourth ring closure in mithramycin biosynthesis. CmmY
responsible for the biosynthesis of the 20-carbon poly- shows strong similarity to putative cyclases such as
ketide backbone of the chromomycin aglycon. Two of DpsY [9] and MtmY [10]. Based on these similarities,
these genes (cmmP and cmmK) are located together in we propose roles for CmmX and CmmY as cyclases
the central region of the cluster, while the acyl carrier involved in fourth and second/third ring closures during
protein gene (cmmS) is located more than 8 kb distant the biosynthesis of chromomycin, respectively.
downstream. CmmP and CmmK are highly similar to KS
(ketosynthase I) and KS (ketosynthase II) homologous
proteins, respectively. It is notable that CmmK contains Post-Polyketide Genes
Three genes (cmmOI, cmmOII, and cmmOIV ) have beena glycine residue instead of the conserved glutamine
residue that is present in most of KS proteins [7]. CmmS identified that would code for proteins exhibiting signifi-
Chromomycin Biosynthetic Gene Cluster
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Table 1. Deduced Functions of the Open Reading Frames of the Chromomycin A3 Cluster
Identity/
Protein aa Proposed Function Similar Protein, Pathway Similarity (%) Accession No.
CmmA 422 O-acyltransferase MdmB, midecamycin 37.7/58.8 A42719
CmmC 408 NDP-C-methyltransferase OrfX, balhimycin 63.2/78.4 CAC48364
CmmD 355 NDP-glucose-synthase LanG, landomycin 56.1/73.8 AAD13545
CmmE 326 NDP-4,6-dehydratase RhoH, rhodomycin 64.4/76.7 BAB87836
CmmF 209 NDP-5-epimerase CalS1, calicheamicin 54.3/74.5 AAM94768
CmmGI 393 Glycosyltransferase MycB, mycinamicin 41.1/60.0 BAC57037
CmmGII 396 Glycosyltransferase MtmGII, mithramycin 43.4/63.8 AAC64927
CmmGIII 397 Glycosyltransferase MtmGIII, mithramycin 48.9/68.5 AAD55583
CmmGIV 421 Glycosyltransferase MtmGIV, mithramycin 51.6/67.9 AAD55582
CmmK 422 KS Sim3, simocyclinone 64.4/76.9 AAL15581
CmmLI 413 Acyl-CoA ligase CloL, clorobiocin 36.6/55.1 AAN65228
CmmLII 528 Acyl-CoA ligase MtmL, mithramycin 54.8/68.1 CAA07759
CmmMI 357 O-methyltransferase MtmMI, mithramycin 49.0/66.7 AAD55585
CmmMII 342 C-methyltransferase MtmMII, mithramycin 52.5/73.0 AAD55584
CmmMIII 250 O-methyltransferase ElmMIII, elloramycin 61.4/76.5 AAG23269
CmmOI 415 Oxygenasea MtmOI, mithramycin 57.7/75.1 CAA07766
CmmOII 557 Oxygenase MtmOII, mithramycin 57.9/72.9 CAA07757
CmmOIV 506 Oxygenase MtmOIV, mithramycin 58.7/72.3 AAC64929
CmmP 422 KS UrdA, urdamycin 75.8/82.7 CAA60569
CmmQ 318 Aromatase MtmQ, mithramycin 50.5/66.8 CAA07760
CmmRI 300 Transcriptional activator Grhr2, griseorhodin 45.1/63.4 AAM33680
CmmRII 198 Transcriptional regulator AclS, aclacinomycin 26.5/51.9 BAB72058
CmmS 83 ACP LanC, landomycin 54.8/67.9 AAD13538
CmmTI 252 Ketoreductase MtmTI, mithramycin 54.2/68.3 CAA07765
CmmTII 253 Ketoreductase MtmTII, mithramycin 61.7/75.9 CAA07756
CmmUI 249 NDP-4-ketoreductase LanR, landomycin 52.0/71.2 AAD13548
CmmUII 251 NDP-4-ketoreductase UrdR, urdamycin 51.4/68.0 AAF72551
CmmUIII 356 NDP-4-ketoreductase AveBIV, avermectin 59.9/74.7 BAC68658
CmmV 460 NDP-2,3-dehydratase MtmV, mithramycin 52.0/69.9 CAB96551
CmmW 336 NDP-3-ketoreductase Gra-orf26, granaticin 54.2/66.8 CAA09647
CmmWI 327 Ketoreductase MtmW, mithramycin 62.5/77.4 AJ459240
CmmX 142 Cyclase SnoO, nogalamycin 59.7/72.7 AAF01807
CmmY 258 Cyclase AknW, aclacinomycin 67.6/81.5 AAF73459
CmrA 325 ATP binding protein MtrA, mithramycin 54.2/70.1 AAC44357
CmrB 250 Membrane protein MtrB, mithramycin 47.9/71.8 AAC44358
CmrX 826 UV-repair system Dra0188 42.7/63.4 AAF12187
a This protein could be expressed as a fusion protein with 378 extra amino acids at the N terminus. This N-terminus region shows similarity
to biotin carboxylases.
cant similarities to FAD-dependent monooxygenases in- to be involved in the ketoreduction step affecting the
3-side chain in mithramycin biosynthesis [12].volved in hydroxylations of different aromatic polyke-
tides. The highest similarity of the cmmOI gene product The chromomycin aglycon contains two methyl groups.
Two methyltransferase genes have been found, cmmMIwas with the MtmOI oxygenase from the mithramycin
cluster [10]. The most similar protein to CmmOII is and cmmMII. The deduced gene products are most simi-
lar to methyltransferases MtmMI and MtmMII from theMtmOII, which has been proposed to act on a tricyclic
intermediate prior to the fourth ring cyclization to form mithramycin cluster [13]. CmmMI shows closer similarity
to MtmMI, which is responsible for the O-methylation4-demethylpremithramycinone [10]. CmmOIV is more
similar to MtmOIV, an oxygenase responsible for the at the 4 position of 4-demethylpremithramycinone.
CmmMII is more similar to MtmMII, which carries outoxidative fourth ring opening of premithramycin B [11].
CmmOII would be involved in the hydroxylation of chro- the C-methylation step at the 9 position of tetracyclic
intermediates. Thus, we propose CmmMI and CmmMIImomycin aglycon, and CmmOIV would be the oxy-
genase responsible for the fourth ring scission to gener- to be methyltransferases involved in 4-O-methylation
and 9-C-methylation of tetracyclic intermediates, re-ate the tricyclic aglycon with the pentyl side chain
attached at C-3. This process, leading ultimately to the spectively.
formation of chromomycin A3, would also require the
participation of a ketoreductase. Three ketoreductase Genes Involved in Glycosylation
Chromomycin A3 contains five deoxysugars attached togenes have been identified in the cluster, cmmTI,
cmmTII, and cmmWI. No role can be assigned at the the aglycon: two D-olivoses, one 4-O-acetyl-L-chro-
mose, one 4-O-acetyl-D-oliose, and one 4-O-methyl-moment for CmmTI and CmmTII (see below). CmmWI
shows similarity to the aldo/keto reductase protein fam- D-oliose. Several genes have been identified that could
be involved in sugar biosynthesis. Two of them (cmmDily (Pfam00248), which includes proteins reported to
have oxidoreductase activity. This protein is also similar and cmmE ) are located together and would direct the
first steps in deoxysugar biosynthesis. CmmD is veryto MtmW, a ketoreductase that has been recently proven
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similar to NDP-D-glucose synthases, and CmmE is very ferases. The highest similarities of the corresponding
proteins were found with mithramycin glycosyltransfer-similar to NDP-D-glucose 4,6-dehydratases [14]. CmmD
and CmmE are proposed to catalyze the first and second ases. The number of glycosyltransferases genes in chro-
momycin cluster does not correspond to the number ofcommon steps in the biosynthesis of chromomycin
deoxysugars. sugar moieties, i.e., one GT is missing. CmmGIV and
CmmGIII are similar to MtmGIV and to MtmGIII, respec-Downstream of cmmDE genes, there are three other
genes (cmmV, cmmW, and cmmUI ). The cmmV product tively, which have been shown to be responsible for
transferring the first (D-olivose) and the second (D-oli-shows strong similarity to dTDP-2,3-glucose dehydra-
tases involved in the C-2 deoxygenation step of other ose) deoxysugars of the trisaccharide to the aglycon
[21]. According to these similarities, CmmGIV andantibiotics [15, 16]. CmmW shows similarity to 3-keto-
reductases, which render hydroxyl groups at C-3 with CmmGIII could transfer the first and second D-olivose
moieties of the trisaccharide, respectively. CmmGII isan equatorial configuration, as is the case of Gra-orf26
involved in D-olivose biosynthesis [15]. CmmV and more similar to MtmGII [22], which suggests its involve-
ment in the formation of the disaccharide. Since theCmmW could be the dehydratase and reductase en-
zymes involved in the 2-deoxygenation step occurring amino acid sequence of CmmGI is equally similar to
those of MtmGIII and MtmGI, it could be involved theo-during biosynthesis of all chromomycin deoxysugars
(sugars A–E). The third gene (cmmUI ) would code for a retically either in the formation of the disaccharide or in
the transfer of the third deoxysugar of the trisaccharide4-ketoreductase. There are two other genes (cmmUII
and cmmUIII ) whose products are similar to 4-ketore- chain.
ductases and that are scattered in the cluster. CmmUI
and CmmUII show highest similarities to UrdR, involved Genes Involved in Regulation
in the biosynthesis of D-olivose in the urdamycin path- Database searches revealed two genes with probable
way [17]. On the other hand, CmmUIII is more similar regulatory function in the cmm cluster, CmmRI and
to 4-ketoreductases involved in L-sugar biosynthesis, CmmRII. CmmRI resembles transcriptional activators of
such as AveBIV from the L-oleandrose biosynthetic the Streptomyces antibiotic regulatory proteins (SARP)
pathway [18]. CmmUIII could be the 4-ketoreductase family. It contains a bacterial transcriptional activator
involved in the biosynthesis of 4-O-acetyl-L-chromose, domain (BAD) (Pfam03704) characteristic of this family
and the two other ketoreductases (CmmUI and CmmUII) of regulators. A second protein, which potentially has a
in the biosynthesis of the D-deoxysugars in chro- regulatory function, is encoded by cmmRII. This gene
momycin A3. could be cotranscribed with two other genes that form
Immediately downstream and convergently tran- part of an ABC transporter system. It contains a putative
scribed to cmmUIII is cmmC, which would code for a conserved domain (COG1695) predicted in several tran-
C-methyltransferase probably involved in the biosynthe- scriptional regulators.
sis of 4-O-acetyl-L-chromose. CmmC shows high simi-
larity to C-methyltransferases involved in branched-
Genes Involved in Self-Resistancechain sugars biosynthesis from different clusters. It shows
In the right part of the cluster, there are three genescloser similarity to C-methyltransferases that will pro-
(cmrA, cmrB, and cmrX) that could be involved in self-duce a C-methyl group at C-3 with an axial configuration
resistance to chromomycins. CmrA and CmrB are simi-[19]. Accordingly, CmmC could be the C-methyltransfer-
lar to ATP binding proteins and to membrane proteins,ase needed for the biosynthesis of 4-O-acetyl-L-chro-
respectively, which form part of type I ABC transportermose. There is another gene, cmmF, whose product
systems [6]. The cmrX gene product resembles one ofresembles proteins proposed to act as 5- or 3,5-epi-
the three subunits (UvrA) of ABC excision nuclease sys-merases and that contains conserved domains for NDP-
tems responsible for DNA repair. It was predicted thatsugar-isomerases (Pfam00908). CmmF could play the
the ABC transporter system (CmrAB) and the CmrX pro-role of an epimerase that is required for the d/l-switch in
tein would be involved in self-resistance to chro-the biosynthesis of the 4-O-acetyl-L-chromose moiety.
momycin.Three chromomycin sugars are decorated by either a
methyl (sugar B) or acetyl groups (sugar A and E) at their
Other GenesC-4 hydroxy groups. The cmmMIII gene would code for
CmmTI contains domains of enoyl-[acyl-carrier-protein]a protein that strongly resembles O-methyltransferases.
reductases (COG0623) and short chain dehydrogenasesThese enzymes methylate sugars once they have been
(Pfam00106). Its closest homolog is MtmTI from theattached to the aglycons [20]. The cmmA product is
mithramycin cluster [8], for which a clear role in mithra-similar to acyltransferases acting both on macrolide
mycin biosynthesis has not been established. It hasaglycons and on sugars already attached to macrolide
been proposed that MtmTI together with MtmX playsaglycons, and it contains a conserved domain of an
some role in polyketide biosynthesis, probably in ringacyltransferase family (Pfam01757). We propose CmmMIII
cyclizations. CmmTII produces significant alignmentsto be the methyltransferase responsible for the 4-O-
with short chain dehydrogenases (Pfam00106). It showsmethylation of the terminal d-oliose of the disaccharide
closer similarity with MtmTII from the mithramycin clus-chain, i.e., the generation of 4-O-methyl-D-oliose, and
ter, which seems to be not essential for mithramycinfor CmmA the role of an acetyltransferase responsible
biosynthesis [10].for the transfer of one or both acetyl groups required
Two putative PKS accessory genes have been identi-for the decoration of the sugars A and E.
Four genes in the cluster would encode glycosyltrans- fied, cmmLI and cmmLII. They code for proteins similar
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to acyl CoA ligases. They also contain conserved do- NMR solvents. This was necessary since this solvent
proved to be the best for the generation of most ofmains for AMP binding (Pfam00501) present in a number
of enzymes that act via an ATP-dependent covalent the NMR data of the new chromomycin derivatives (the
chromomycin A3 assignments are available as Supple-binding of AMP to their substrates.
mental Data with this article online for comparison). Our
13C assignments of the aglycon signals correlate withRational Design of New Chromomycins
the recently published data on durhamycin A [23], whichAn experiment was carried out to prove the involvement
were also recorded in pyridine. For better comparisonof the cmm genes in chromomycin biosynthesis. This
with other aureolic acid drugs, we also used the stan-experiment was also designed to generate new chro-
dard ring labeling (A–E) of the sugar residues (see Figuremomycin derivatives with novel but predicted structures
1A), which for unclear reasons was not used historicallyand with potential antitumor activity. We chose the
for chromomycin A3.cmmWI gene that codes for a protein showing strong
Chromomycin SA (Figure 1A, 2)similarity to MtmW (62.5% identity) [12]. Inactivation of
The molecular ions identified in the negative fast atommtmW leads to a chemically unstable compound that
bombardment mass spectrum at m/z 1123 ([M–H]) andcan undergo various chemical reactions that conse-
in the positive FAB MS at m/z 1147 ([MNa]) allowedquently lead to the production of several novel mithra-
the deduction of the molecular formula of C54H76O25,mycin derivatives bearing shorter side chains attached
which was also supported by the NMR data and con-at C-3 instead of the usual pentyl side chain, with one of
firmed by HR-ESI-MS (1123.4592 observed, calculatedthem (mithramycin SK) showing a dramatically improved
for C54H76O25: 1123.4603). Compound 2 was obtained astherapeutic index compared to the parent drug mithra-
yellow amorphous solid, which showed identical UV andmycin [12]. We therefore envisaged that we could create
similar IR data (see Experimental Procedures) as chro-analogous novel chromomycin derivatives that would
momycin A3. The 1H-NMR spectrum of compound 2differ from the corresponding mithramycin derivatives
closely resembled that of chromomycin A3, except thatwith respect to their sugar residues.
three characteristic signals of the pentyl side chainThe cmmWI gene was in vitro mutated by inserting
attached at C-3 of chromomycin A3 were missing,an apramycin resistance cassette in the same direction
namely 3-H, 4-H, and that of the terminal methyl groupof transcription as the gene (Figure 2A). This construct
(5-H3). The 13C-NMR spectrum showed only 54 signals,was introduced into S. griseus by intergeneric conjuga-
i.e., three signals less than 1, due to the modified 3-sidetion with E. coli and transconjugants selected by their
chain. Compared to the parent compound 1, typicalresistance to apramycin and then further tested for their
signals of the pentyl side chain are missing, includingsensitivity to thiostrepton as a consequence of a double
the terminal methyl group, the two hydroxylated methinecrossover. Southern hybridization demonstrated the oc-
carbons C-3 and C-4, and the C-2 keto group, whichcurrence of a double recombination event (Figure 2B).
normally represents the most downfield signal ( 213.5).A mutant strain (C60WI) was selected and tested for
Instead, compound 2 has a new carbonyl further upfieldchromomycin production. No chromomycin A3 was de- at  179.7, which is typical for an acid carbonyl. Thus,tected in cultures of C60WI, proving the involvement of
the side chain of compound 2 consists only of two car-this region in chromomycin biosynthesis. Instead, this
bons, and structure 2 was deduced for this compound,mutant accumulated three new compounds (designated
called chromomycin SA, in analogy to the recently de-as chromomycin SA, SK, and SDK; Figures 2C and 1A),
scribed mithramycin SA [12].with chromomycin SK being the major accumulated
Chromomycin SK (Figure 1A, 3)compound. All three compounds showed the same UV
The molecular ions identified in the negative FAB massabsorptions as chromomycin A3, suggesting that they spectrum at m/z 1151 ([M–H]) and in the positive FABall contain the tricyclic chromophore.
MS at m/z 1175 ([MNa]) are in agreement with a
molecular formula of C56H80O25, which also was sup-
Structural Elucidation of Compounds ported by the NMR spectra and the high-resolved ESI
Accumulated by Mutant C60WI mass spectrum (observed, 1151.5053; calculated for
The three compounds accumulated by mutant C60WI C56H80O25, 1151.4916). Compound 3 was obtained as yel-
were purified by preparative HPLC from cultures grown low amorphous solid, which also showed almost identi-
on R5A medium. Purification of the compounds was cal UV and similar IR data (see Experimental Procedures)
complicated since they were rather unstable. The amounts as chromomycin A3.
of purified compounds obtained from 100 plates were As expected from the design of the inactivation exper-
28.2 mg for chromomycin SA, 34.8 mg for chromomycin iment, the 1H-NMR, although in general similar to those
SK, and 34 mg for chromomycin SDK, making a total of compounds 1 and 2, showed differences with respect
of 97 mg. Under similar cultivation conditions, 169 mg to the signals of the 3-side chain. The terminal methyl
chromomycin A3 can be obtained. group ( 2.47) appeared as a singlet whose chemical
Chromomycin A3 (Figure 1A, 1) shift indicates a carbonyl neighborhood. Two methine
Although the correct structure of chromomycin A3 (1) protons whose 3 Hz coupling indicated a direct neigh-
was published already ca. 20 years ago, we needed to borhood were identified as part of this side chain,
reassign the 1H- and 13C-NMR signals since we used d5- namely 1-H (a doublet of a doublet at  5.37, J  3 and
pyridine as an NMR solvent, which has never been used 1 Hz), and 2-H (a doublet at  4.70, J  3 Hz). Both of
before on chromomycins and causes significantly differ- their chemical shifts indicated that these protons were
attached to an oxygen-bearing carbon. All other signalsent NMR spectra compared to those recorded in other
Chemistry & Biology
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Figure 2. Generation and Analysis of Mutant C60WI
(A) Scheme representing the replacement in the chromosome of the wild-type cmmWI gene by the in vitro mutated one. aac(3)IV, apramycin-
resistance gene; tsr, thiostrepton-resistance gene; bla, -lactamase gene.
(B) Southern hybridization using the 9.6 kb PstI fragment as probe. Lane 1, PstI-digested chromosomal DNA from mutant C60WI; lane 2, PstI-
digested chromosomal DNA from wild-type strain.
(C) HPLC analysis of a culture of mutant C60WI.
of the 1H-NMR spectrum were very similar to those of NMR spectrum and the highly resolved ESI MS (ob-
served, 1149.4783; calculated for C56H78O25, 1149.4759).compounds 1 and 2, indicating that the sugars and the
remaining aglycon was unchanged. The 13C-NMR spec- Compound 4 was isolated as yellow amorphous solid,
which showed similar UV and IR spectra (see Experi-trum showed 56 signals, of which the most downfield-
shifted signals at  207.2 was assigned to C-3, since a mental Procedures) with chromomycin A3 as well as the
above-described derivatives.long-range 2JC-H coupling with the 4-H3 singlet ( 2.47)
was observed in the HMBC spectrum. The other unique Again, the 1H-NMR was similar to that of chromomycin
A3, except for the missing signals for 2-H and 3-H.carbon, compared to the 13C-NMR spectra of structures
1 and 2, is the signal at  28.9, which could be assigned Like for chromomycin SK (3), a downfield-shifted methyl
group singlet at  2.43 was observable whose chemicalto C-4, since its chemical shift indicates a carbonyl
neighborhood, and its attached protons show a 3JC-H shift and missing coupling indicates a carbonyl neigh-
bor, assigned as 4-H3. The 1-H signal ( 5.50) appearscoupling with C-2 ( 76.2) in the HMBC spectrum. Thus,
the side chain of compound 3 was unambiguously iden- as a doublet (J  1Hz) like in chromomycin, also indicat-
ing a carbonyl neighbor. Combining all this information,tified as identical with the butyl side chain recently de-
scribed for mithramycin SK. In summary, the MS, 1H- it could be concluded that the 3-side chain consists of
only four carbons, two being carbonyl groups. This wasNMR, and 13C-NMR data, in comparison with the data
of chromomycin A3 (1), reveal structure 3, which is called confirmed by the 13C-NMR spectrum, which showed the
two postulated carbonyl signals of C-2 and C-3 in thechromomycin SK in analogy to mithramycin SK.
Chromomycin SDK (Figure 1A, 4) downfield region of the spectrum at  198.6 and 199.5,
which is typical for a -dicarbonyl arrangement, alongThe molecular ion identified in the negative fast atom
bombardment mass spectrum at m/z 1149 (M–H) and with the C-4 methyl signal at  26.4 neighboring one of
these carbonyls. In summary, the structure of 4 wasthe positive FAB MS at m/z 1173 (M–Na) allowed the
deduction of the molecular formula to be C56H78O25, deduced for the compound.
The structures of chromomycin SK, SA, and SDK (Fig-which is supported by 56 observed signals in the 13C-
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Figure 3. Formation of Chromomycin Derivatives
Formation of chromomycins SK (3) and SDK (4) through a Favorskii-like rearrangement and of chromomycin SA (2) through retro-aldol-type
cleavage of the reactive product 5, proposed to be generated by the inactivation of the ketoreductase-encoding gene cmmWI.
ure 1A) were expected from our analogous previous 3 involved in self-resistance to chromomycin. Genes
encoding most of the activities that are required forexperiments with mithramycin. As in the case of mithra-
chromomycin biosynthesis were identified within themycin, a -diketo compound (5) is expected from the
cluster. Exceptions are the absence of a fifth glycosyl-inactivation of ketoreductase CmmWI (Figure 3). The
transferase gene and the identification of only one sugarhighly functional and thus reactive 3-side chain of 5,
acyltransferase gene. Genes are organized in at leastwhich contains two keto-functions in  position to each
ten transcriptional units that, in most cases, includeother separated by a carbon bearing another oxygen
genes with no related roles in chromomycin biosynthe-atom, triggers a Favorskii-like rearrangement for which
sis (i.e., PKS genes together with sugar biosynthesisan 1,2 acyl shift induced by deprotonation of the central
genes). It must be noted that genes involved in polyke-alcohol can be envisaged. This is either followed by
tide biosynthesis are scattered throughout the cluster.addition of water on the resulting aldehyde and conse-
Particularly, it is noticeable that cmmS (ACP), cmmYquent departure of formic acid (leading to chromomycin
(cyclase), and cmmQ (aromatase) are unusually locatedSK) or just by departure of formaldehyde (leading to
when compared to other polyketide clusters. A similarchromomycin SDK). Chromomycin SA also gives indi-
situation has been described for the medermycin clusterrect evidence for the labile structure 5, since its forma-
[24]. This genetic organization implies that the expres-tion from 5 is possible through attack of water at the
sion of the different genes involved in the biosynthesiscarbonyl adjacent to the methoxy group followed by
of the chromomycin aglycon will need to be tightly coor-retro-aldol cleavage to yield 2 and hydroxyacetone.
dinated.
It is predicted that the biosynthesis of the chro-Antitumor Activity
momycin aglycon would follow similar steps as that forThe antitumor activity of the three novel chromomycin
mithramycin, since both compounds share the same
derivatives was tested against a variety of tumor cell
aglycon structure (Figures 1A and 4). In the mithramycin
lines (Table 2). Compilation of the average log (GI50) val- pathway, the first stable compound is the 4-demethyl-
ues showed that the three compounds were clearly ac- premithramycinone, which is then O-methylated at the
tive, although the activity levels were lower than those 4-position to generate premithramycinone [13]. Several
for the natural chromomycin A3 compound. However, genes could have a role in the biosynthesis of premithra-
when compared with mithramycin, the three compounds mycinone in the chromomycin A3 pathway. The minimal
showed similar levels of activity. PKS encoded by the cmmP, cmmK, and cmmS genes
would synthesize the 20-carbon polyketide backbone
Discussion that then would be folded and cyclized with the partici-
pation of the aromatase CmmQ, the cyclases CmmX and
The chromomycin A3 cluster of Streptomyces griseus CmmY, and probably the reductase CmmTI. In addition,
subsp. griseus consists of 36 genes: 31 coding for struc- formation of 4-demethyl-premithramycinone would re-
quire the introduction of two oxygen atoms in the 4tural proteins, 2 for pathway regulatory proteins, and
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Table 2. Antitumor Activity Tests of Chromomycin Derivatives Generated in This Work
Log (GI50)a
Tumor Cell Lines Mithramycin Chromomycin A3 Chromomycin SA Chromomycin SK Chromomycin SDK
Prostate DU-145 7.77 8.70 7.72 8.70 7.93
LN-caP 8.82 9.60 7.84 7.91 7.84
Ovarian IGROV 7.72 8.70 7.70 7.95 7.84
Breast SK-BR-3 7.52 8.40 7.45 7.78 7.62
Melanoma SK-MEL-28 7.84 8.71 7.79 7.96 8.02
NSCL A549 7.40 7.85 7.39 7.71 7.77
Pancreas PANC-1 7.74 8.68 7.66 7.94 7.85
Colon HT-29 7.51 8.33 7.12 7.67 7.68
LoVo 7.82 8.46 7.69 6.51 7.79
Cervix HELA 8.05 8.76 7.79 8.00 7.92
For comparison, values for chromomycin A3 and mithramycin are also shown.
a GI50, 50% growth inhibition.
and 12a position, probably catalyzed by the oxygenase tion of glucose-1-phosphate to NDP-d-glucose by the
action of CmmD (NDP-glucose synthase) and furtherCmmOII. Methylation of 4-demethyl-premithramycinone
conversion to NDP-4-keto-6-deoxy-glucose by CmmEcatalyzed by the CmmMI methyltransferase would lead
(NDP-glucose 4,6-dehydratase). Next, the C-2 deoxy-to the synthesis of premithramycinone.
genation of this last intermediate would occur, requir-Formation of premithramycinone would be followed
ing a 2,3-dehydration and a 3-reduction step catalyzedby several glycosylation steps as well as the C-methyla-
by CmmV and CmmW, respectively. Accordingly, thetion at the 9 position. Four glycosyltransferases have
reaction product of CmmW would be NDP-4-keto-2,6-been identified in the cluster. CmmGIV and CmmGIII
dideoxy-d-glucose, which might be the last commonwould most probably catalyze the transfer of the first
intermediate in the biosynthesis of all chromomycinand second D-olivose units that form part of the trisac-
deoxyhexoses. Reduction of this intermediate at C-4charide chain attached at the 12a position of premithra-
will produce NDP-D-olivose or NDP-D-oliose dependingmycinone. CmmGII and probably also CmmGI would
on the stereocontrol enforced by the involved ketore-be involved in the formation of the disaccharide chain
ductase. The 4-ketoreductases CmmUI and CmmUII areattached at 8 position. Transfer of the third deoxysugar
most probably involved in these processes. From NDP-of the trisaccharide could be carried out by any of these
4-keto-2,6-dideoxyglucose, the biosynthesis of L-olivo-four glycosyltransferases, most likely by CmmGIV or,
mycose would require a C-3 methylation (catalyzed byalternatively, by a not yet identified GT outside of the
CmmC), 5- or 3,5-epimerization (catalyzed by CmmF),cluster. The same situation is found in the mithramycin
and a 4-ketoreduction step (catalyzed by CmmUIII). Thecluster, in which only four glycosyltransferase genes
CmmC-catalyzed C-3 methylation would take place onhave been identified for the transfer of five sugars, and
a D-deoxyhexose with overall inversion of configurationthere was no candidate for transferring the third sugar
at C-3, resulting in a methyl group with equatorial config-of the trisaccharide chain [21, 22]. However, indirect
uration. Epimerization at C-5 would occur next and mostevidence suggests that MtmGIV is responsible for the
probably would be carried out by CmmF. Alternatively,transfer of both the first and the third sugar of the trisac-
the C-methylation could occur with retention of thecharide chain [25]. Thus, CmmGIV is also the most prob-
3-configuration (i.e., axial methyl group), and the epi-
able candidate to catalyze this glycosylation step. The
merase would be a 3,5-epimerase. Once the different
CmmMII methyltransferase would catalyze a C-methyla-
deoxyhexoses were transferred to the polyketide back-
tion that most probably would occur once the trisac- bone or growing oligosaccharide chains, 4-O-methyla-
charide chain has been formed, as it happens during tion of sugar B and 4-O-acetylations of sugars A and
mithramycin biosynthesis [13]. By analogy with the E should occur to generate 4-O-methyl-D-oliose, 4-O-
mithramycin biosynthesis, one of the final steps in chro- acetyl-D-oliose, and 4-O-acetyl-L-chromose, respec-
momycin A3 biosynthesis will be the oxidative cleavage tively. The CmmMIII methyltransferase would catalyze
of the fourth ring of a fully glycosylated tetracyclic inter- the O-methylation from D-oliose to 4-O-methyl-D-oli-
mediate along with a decarboxylation followed by the ose, and the acetylations of sugars A and E would proba-
ketoreduction of the thereby formed pentyl side chain. bly be catalyzed by the CmmA acyltransferase.
The result of these biosynthetic key steps is the forma- The cmm cluster also contains an ABC transporter
tion of a fully glycosylated molecule with a tricyclic agly- system (cmrAB) and a UV-repair system (cmrX) that can
con at whose 3 position the important highly function- contribute to self-resistance to chromomycin A3. The
alized pentyl side chain is attached. Candidates for involvement of these genes in chromomycin resistance
catalyzing these reactions are the oxygenase CmmOIV was demonstrated by expressing a cosmid containing
and the ketoreductase CmmWI. these genes in the chromomycin-sensitive strain S. al-
Chromomycin A3 contains three unusual deoxysugar bus that afterwards became chromomycin resistant. Al-
units: 4-O-acetyl-D-oliose, 4-O-methyl-D-oliose, and though similar types of genes were also found in the
4-O-acetyl-L-chromose. The cmm cluster contains all mithramycin pathway, they do not protect S. argillaceus
genes needed for the biosynthesis of these sugars (Fig- from chromomycin, suggesting a great specificity of
these transporters [26].ure 5). The first two enzymatic steps would be the activa-
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Figure 4. Proposed Pathway for the Biosynthesis of Chromomycin A3
In many cases, genetic organization of biosynthetic level of the biosynthetic genes. Both gene clusters show
very different genetic organization. This is especiallyclusters for structurally related antibiotics is quite simi-
lar. In this context, the striking correspondence in the noticeable in relation to genes involved in the biosynthe-
sis of the aglycon. Thus, in the case of the mithramycinorganization of the aminocoumarin gene clusters is no-
ticeable: the biosynthetic genes for each structural moi- cluster, the genes required for the formation of 4-demethyl-
premithramycinone are all grouped in the central partety of the aminocoumarin antibiotic are grouped to-
gether, and the order of the genes within each group is of the cluster, while in the chromomycin A3 cluster these
genes are scattered throughout the cluster. However,identical [27]. However, in the case of chromomycin
A3, an antibiotic closely related to mithramycin in its some other groups of genes, such as resistance genes,
are organized in a similar way in both clusters. It haschemical structure, this similarity is not reflected at the
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rivatives were generated that differed in the length and
structure of their side chains [12]. We reasoned that by
inactivating cmmWI we could first prove the involvement
of this gene in the biosynthesis of chromomycin A3, and
at the same time we could generate novel chromomycin
derivatives with promising biological activity. This hy-
pothesis turned out to be correct, since the C60WI mu-
tant lost the capability of producing chromomycin A3
and the three novel compounds showed interesting anti-
tumor activity. They consisted of fully glycosylated chro-
momycins only differing from the parent compound in
the structure and length of their side chains, as was
anticipated. These results also confirm that CmmWI is
the ketoreductase acting on the side chain of the ag-
lycon.
Significance
The biosynthetic gene cluster of the antitumor anti-
biotic chromomycin A3 from Streptomyces griseus
subsp. griseus shows a different genetic organization
to that of the closely structurally related mithramycin.
Inactivation of a ketoreductase gene cmmWI involved
in side-chain reduction has been proven to be an ap-
propriate target to generate three novel and active
chromomycin A3 derivatives. Knowledge of the chro-
momycin A3 cluster has allowed the identification ofFigure 5. Proposed Pathways for the Biosynthesis of the Deoxy-
sugars in Chromomycin A3 the biosynthetic pathways for novel deoxysugars, es-
pecially for 4-O-acetyl-L-chromose. In this context,
several tailoring genes (acetylation, methylation) forbeen suggested that aromatic polyketide clusters could
sugar modification have been identified that could bebe transferred horizontally between different Streptomy-
useful genetical/biochemical tools for combinatorialces species, and thus very similar antibiotic clusters can
biosynthesis, to generate novel derivatives from bio-be found in distantly related species [28]. In the case
active compounds.of the mithramycin and chromomycin clusters, if this
transfer occurred, there were probably gene rearrange-
Experimental Proceduresments through evolution that could be responsible for
the differences in gene organization between these two
Microorganisms, Culture Conditions, and Plasmidsclusters. On the other hand, we could find and putatively
Streptomyces griseus subsp. griseus ATCC 13273, chromomycin
assign all genes found in the chromomycin pathway with A3 producer, was used as donor of chromosomal DNA. For sporula-
the corresponding genes of the mithramycin pathway. tion on solid medium, it was grown at 30	C on plates containing A
medium [22]. For growth in liquid medium, the organism was grownApparently, the enzymes performing the biosynthesis of
either on TSB medium (trypticase soya broth, Oxoid) or in R5Asuch biosynthetically closely related molecules have to
medium [22]. Streptomyces albus J1074 (ilv-1, sal-2) [29] was usedarrange themselves in a similar way so that the passing
as host for expression of chromomycin genes. Escherichia coliof the same or very similar intermediates can be
ED8767 [30] was used to construct the gene library, and E. coli DH10B
achieved in the most efficient way, although the gene (Invitrogene) was used as host for subcloning. E. coli ET12567
arrangement of the two pathways is totally different. (pUB307) [29] was used as donor for intergeneric conjugation. When
plasmids containing clones were grown, the medium was supple-Thus, one could suggest that the gene arrangement
mented with the appropriate antibiotics as follows: 5 or 25 g/mldoes not influence the arrangement of the proteins at
thiostrepton for liquid or solid cultures, respectively, 100 g/ml am-all, and the organization of the biosynthetic enzymes
picillin, 25g/ml apramycin, 20g/ml tobramycin, 25g/ml kanamy-seems to be a self-driven, autocatalytic process.
cin, or 25 g/ml chloramphenicol. The bifunctional (E. coli-Strepto-
The involvement of the isolated cluster in chro- myces) cosmid pKC505 [29] was used to construct the S. griseus
momycin biosynthesis was unequivocally proven by two subsp. griseus DNA library. pUC18, pHZ1358 [29], pUK21 [31], and
pIJ2925 [29] were used for subcloning.different approaches. First, it was proved that the cluster
contained a chromomycin-resistance determinant. This
is a strong indication that the cluster is actually involved DNA Manipulation
Plasmid DNA preparations, restriction endonuclease digestions, al-in chromomycin biosynthesis, since in most antibiotic
kaline phosphatase treatments, DNA ligations, Southern hybridiza-biosynthetic gene clusters resistance determinants are
tion, and other DNA manipulations were performed according tolinked to biosynthetic genes. A further definite proof
standard techniques for Escherichia coli [30] and Streptomyces [29].was obtained through the generation of a nonproducer
Preparation of S. albus protoplasts, transformatio, and selection
mutant by specifically inactivating the cmmWI gene. We of transformants were carried out as described [29]. Intergeneric
have recently shown that by inactivating an equivalent conjugation from E. coli ET12567 (pUB307) to S. griseus subsp.
griseus was performed as described [29].gene in the mithramycin cluster, active mithramycin de-
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Construction and Analysis of the Cosmid Library Physicochemical Properties of the New Compounds
GeneralA genomic library of S. griseus subsp. griseus total DNA was con-
structed in cosmid pKC505. The library was analyzed by in situ The optical rotations were measured using a Perkin-Elmer 241 polar-
imeter, and the fast atom bombardment (FAB) and electrospraycolony hybridization with two types of probes, a PKS and an ABC
probe. The PKS probe consisted of a 1 kb BamHI fragment con- ionization mass spectra (ESI MS) were acquired with a Finnigan
MAT LCQ mass spectrometer. UV spectra were recorded on a Variantaining PKS genes (the 3 end of mtmP and the 5 end of mtmK of
the mithramycin gene cluster) [8]. The ABC probe was generated by CARY50 spectrophotometer, and the IR spectra were obtained from
pure samples pressed in KBr disks using a Bio-Rad FTS3000MX FTPCR amplification using two degenerate oligonucleotides specially
designed to amplify ATP binding domains of ABC transporters in IR. All NMR data were recorded on a Varian Inova 400 instrument
at B0 9.4 T.antibiotic producer microorganisms [6]. The synthetic olinonucleo-
tides used were primer WA (5-GATCGAATTCGGG(C)G(C)A(C)CA Chromomycin SA
ACGGCGCG(C)GGCAAG-3) and primer WB (5- GATCAAGCTTGA []23D (c 0.0052, MeOH): 12	. MS: FAB (ve) m/z 1123; FAB (ve)
GGC(T)CGG(T)TGGTG(C)GGC(T)TCGTC-3) (EcoRI and HindIII sites m/z 1147 (MNa); Ion Spec HR ESI calcd. for C54H75O25 1123.4603,
in the respective primers are underlined). found 1123.4592. IR 
max (KBr): 3426 (OH), 2920 (CH), 1690 (C  O),
1650, 1630, 1450 (C  C), 1430, 1170, 1105, and 1051 cm1. UV
DNA Sequencing maxMeOH (): 430 (5900), 317 (6100), and 281 (32300) nm. NMR data:
Sequencing was performed on double-stranded templates derived see Supplemental Data available with this article online.
from different clones in pUC18 and by using the dideoxynucleotide Chromomycin SK
chain termination method and the Cy5 AutoCycle Sequencing Kit []23D ( c 0.0026, MeOH): 42	. MS: FAB (ve) m/z 1151; FAB (ve)
(Amersham Pharmacia Biotech). Both DNA strands were sequenced m/z 1174 (MNa); Ion Spec HR ESI calcd. for C56H79O25 1151.4916,
with primers supplied in the kits or with internal oligoprimers (17- found 1151.5063. IR 
max (KBr): 3422 (OH), 2930 (CH), 1734, 1700sh
mer) using an ALF-express automatic DNA sequencer (Amersham (C  O), 1630, 1447 (C  C), 1373, 1169, 1121, and 1044 cm1. UV
Pharmacia Biotech). Computer-aided database searching and se- maxMeOH (): 422 (10700), 316 (11500), and 285 (39900) nm. NMR data:
quence analysis were carried out using the University of Wisconsin see Supplemental Data available with this article online.
Genetics Computer Group program package (UWGCG) and the Chromomycin SDK
BLAST program. []23D (c  0.0028, MeOH):  48	. MS: FAB (ve) m/z 1149; FAB
(ve): m/z 1172 (MNa); Ion Spec HR ESI calcd. for C56H77O25
Generation of Mutant C60W1 1149.4759, found 1149.4783. IR 
max (KBr): 3428 (OH), 2930 (CH),
For the generation of mutant C60W1, plasmid pC7WI was con- 1740, 1710 (C  O), 1632, 1447 (C  C), 1374, 1170, 1121, and 1071
structed. A 9.6 kb PstI fragment containing cmmMI, cmmGI, cm1. UV maxMeOH (): 420 (64000), 317 (7900), and 284 (32200) nm.
cmmOIV, cmmWI, cmmLI, cmrB, cmrA, cmmRII, and the 5 end of NMR data: see Supplemental Data available with this article online.
cmrX was subcloned into the PstI site of pUK21, generating pKW1.
Then, an apramycin-resistance cassette was inserted as a blunt-
Antitumor Tests
ended HindIII-BamHI fragment into the unique ScaI site located
The antitumor activity of the compounds was tested against a variety
within cmmWI, generating pKW1A. The insert from this plasmid was
of tumor cell lines. Quantitative measurement of cell growth and
rescued as a HindIII-XbaI (using these sites from the polylinker)
viability was carried out by using a colorimetric type of assay usingfragment and subcloned into the same sites of pIJ2925. Finally, the
sulforhodamine reaction [32].resultant construct was digested with BglII, and the insert flanked
by two BglII sites was subcloned into the BamHI site of pHZ1358,
Supplemental Datagenerating pC7W1. In this construct, the apramycin-resistance gene
Two tables showing 1H-NMR data of compounds chromomycins SAis transcribed in the same direction as cmmWI. pC7W1 was intro-
(2), SK (3), and SDK (4) in comparison with chromomycin A3 (1) atduced by intergeneric conjugation into S. griseus, and apramycin-
400 MHz in d5-pyridine and 13C-NMR data of chromomycins SA (2),resistant, thiostrepton-sensitive transconjugants were selected for
SK (3), and SDK (4) in comparison with chromomycin A3 (1) at 100.6further characterization.
MHz  in ppm are available online at http://www.chembiol.com/
cgi/content/full/11/1/21/DC1.Determination of Minimal Inhibitory Concentrations
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